Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
C. Esquinas, M. Miravitlles, E. Monso, S. Vila, A. Marin, R. Hervas, M. Garcia, C. de la Roza, A. Torres, J. Morera (Barcelona, Badalona, Spain). Factors associated with sputum purulence in stable moderate to severe COPD patients. Eur Respir J 2007; 30: Suppl. 51, 1373

Member's Comments

No comment yet.

Related content which might interest you: Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 Factors associated with frequent exacerbations in patients with severe asthma Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001 Sputum microbiota in moderate versus severe patients with COPD Source: Eur Respir J 2014; 43: 1787-1790 Year: 2014 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Factors associated with exacerbations in US patients with COPD Source: Annual Congress 2009 - Exacerbations and characteristics of COPD Year: 2009 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Static hyperinflation and respiratory disability were associated with frequent-exacerbation phenotype in patients with severe COPD Source: International Congress 2016 – Exploring mechanisms in health and disease Year: 2016 Predictors of sputum eosinophilia in severe asthma Source: Virtual Congress 2020 – Clinical parameters in severe asthma Year: 2020 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Determinants of dyspnea in stable COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 Markers of systemic inflammation are associated with increased symptoms and respiratory exacerbations among smokers with preserved spirometry in SPIROMICS Source: International Congress 2018 – Biomarkers in COPD and asthma Year: 2018 Both moderate and severe exacerbations accelerate physical activity decline in COPD patients Source: Eur Respir J, 51 (1) 1702110; 10.1183/13993003.02110-2017 Year: 2018 Poor quality of life is associated with frequent exacerbations in moderate-to-severe COPD patients Source: Eur Respir J 2001; 18: Suppl. 33, 190s Year: 2001 Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012 Induced sputum concentrations of mucin in patients with asthma and chronic cough Source: Eur Respir J 2007; 30: Suppl. 51, 61s Year: 2007 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015